Evidence map›Paper›PMID 29891591›Full record

ArticleBlood advances2018

A case of acute myeloid leukemia with promyelocytic features characterized by expression of a novel

Christopher A Miller, Christopher Tricarico, Zachary L Skidmore, Geoffrey L Uy, Yi-Shan Lee, Anjum Hassan, Michelle D O'Laughlin, Heather Schmidt, Ling Tian, Eric J Duncavage and 4 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Blood advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. [Advances in the recognition of acute myeloid leukemia with RARG-rearrangement].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2022
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Acute Myeloid Leukemia withOncoTargets and therapy · 2020
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Christopher A MillerDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.
Christopher TricaricoDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.
Zachary L SkidmoreMcDonnell Genome Institute, Washington University, St. Louis, MO; and.
Geoffrey L UyDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.
Yi-Shan LeeDepartment of Pathology and Immunology.
Anjum HassanDepartment of Pathology and Immunology.
Michelle D O'LaughlinMcDonnell Genome Institute, Washington University, St. Louis, MO; and.
Heather SchmidtMcDonnell Genome Institute, Washington University, St. Louis, MO; and.
Ling TianDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.
Eric J DuncavageDepartment of Pathology and Immunology.
Malachi GriffithMcDonnell Genome Institute, Washington University, St. Louis, MO; and.
Obi L GriffithDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.
John S WelchDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.
Lukas D WartmanDepartment of Medicine, Washington University School of Medicine, St. Louis, MO.
James S. McDonnell Foundation · USWashington University in St. Louis · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
RETINOIDS IN HEMATOPOIESISR01HL128447 · NHLBI · WASHINGTON UNIVERSITY · PI WELCH, JOHN S · 2016 to 2020
$1.9M
COMPREHENSIVE INFORMATIC ANALYSES OF AML GENOMES AND EPIGENOMESR50CA211782 · NCI · WASHINGTON UNIVERSITY · PI Christopher A Miller · 2017 to 2026
$1.5M
HISTONE H3 METHYLATION AND EPIGENOMICS IN ACUTE LEUKEMIAK08CA166229 · NCI · WASHINGTON UNIVERSITY · PI WARTMAN, LUKAS D · 2013 to 2017
$768k
Integrated Analysis & Interpretation of Whole Genome Exome & Transcriptome SequenR00HG007940 · NHGRI · WASHINGTON UNIVERSITY · PI GRIFFITH, MALACHI · 2017 to 2019
$724k
DEFINING THE REGULATORY, NON-CODING, MUTATIONAL LANDSCAPE OF BREAST CANCERK22CA188163 · NCI · WASHINGTON UNIVERSITY · PI GRIFFITH, OBI L. · 2014 to 2016
$515k
INTEGRATED ANALYSIS & INTERPRETATION OF WHOLE GENOME, EXOME & TRANSCRIPTOME SEQUENCE DATA IN CANCERK99HG007940 · NHGRI · WASHINGTON UNIVERSITY · PI GRIFFITH, MALACHI · 2015 to 2016
$264k
NCI NIH HHS K08 CA166229NCI NIH HHS K22 CA188163NCI NIH HHS P30 CA091842NCI NIH HHS R50 CA211782NHGRI NIH HHS K99 HG007940NHGRI NIH HHS R00 HG007940NHLBI NIH HHS R01 HL128447
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene Expression Regulation, LeukemicLeukemia, Promyelocytic, AcutemRNA Cleavage and Polyadenylation FactorsOncogene Proteins, FusionPPAR gammaAdultChromosomes, Human, Pair 15Chromosomes, Human, Pair 17HumansMaleTranslocation, Geneticcleavage factor Im, humanmRNA Cleavage and Polyadenylation FactorsOncogene Proteins, FusionPPAR gammaPPARG protein, human

Identifiers

PMID29891591
PMCPMC5998929
OpenAlexW2808439336

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.